TAO Synergies Inc.

TAOX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.51

-$0.29 (-6.04%)

Sep 22, 2026, 12:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-6.04%

(1D)

Rating

Updated: Aug 18, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $33.7M

1D Range

4.51 5.04

52W Range

3.07 10

Valuation (TTM)

PE -1.20

PB 2.07

EV/EBITDA -1.99

Valuation (NTM)

Forward PE N/A

Forward PEG -0.21

Price Target N/A

Cash Flow

FCF Yield -17.3%

SBC Adj. FCF Yield -18.7%

SBC Impact -8.0%

Margins

Gross Margin 99.9%

Operating Margin -1085.3%

FCF Margin -803.0%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | N/A

Dil EPS 3Y | 5Y 63.1% | N/A

FCF 3Y | 5Y -11.1% | N/A

Returns

ROA -78.9%

ROE -81.2%

ROIC -41.8%

Financial Health

Net Cash

$19.18M

Current Ratio 19.99

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to comba...

Sector Technology

Industry Software - Application

Employees 5

IPO Date Jul 1, 2025

Website www.taosynergies.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞